Advertisement
Singapore markets close in 5 hours 26 minutes

  • Straits Times Index

    3,434.74
    +19.23 (+0.56%)
     

  • Nikkei

    40,666.78
    +86.02 (+0.21%)
     

  • Hang Seng

    18,039.08
    +60.51 (+0.34%)
     

  • FTSE 100

    8,171.12
    +49.92 (+0.61%)
     

  • Bitcoin USD

    58,903.52
    -1,970.04 (-3.24%)
     

  • CMC Crypto 200

    1,234.07
    -100.85 (-7.55%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • Dow

    39,308.00
    -23.90 (-0.06%)
     

  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     

  • Gold

    2,369.40
    0.00 (0.00%)
     

  • Crude Oil

    83.88
    0.00 (0.00%)
     

  • 10-Yr Bond

    4.3550
    -0.0810 (-1.83%)
     

  • FTSE Bursa Malaysia

    1,617.06
    +1.74 (+0.11%)
     

  • Jakarta Composite Index

    7,247.16
    +50.40 (+0.70%)
     

  • PSE Index

    6,505.54
    +55.51 (+0.86%)
     

Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France

Reuters
·1-min read
Novo Nordisk logo above the entrance to their offices in Hillerod

PARIS (Reuters) - French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish pharmaceutical company Novo Nordisk in France, his office said, pitching it as a sign of newly restored French industrial competitiveness.

The investment, for which no detail was provided by Macron's office, will be based in Chartres, west of Paris, where Novo already employs nearly 2,000 people. Novo is known for its hugely popular anti-obesity drug Wegovy.

The Elysee palace deemed it the most significant investment in the health sector of Macron's mandates so far and said it would create 500 jobs.

($1 = 0.9168 euros)

(Reporting by Michel Rose, Editing by Dominique Vidalon)